Cancer Clinical Trial - Minneamrita - Minnelide 101

CONDITION(S): Breast cancer, Pancreatic cancer - TRIAL: A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors (Minnelide 101)

Drug

Minnelide + nab-paclitaxel

Trial Type

Treatment

Phase

Phase 1

Condition

Pancreatic cancer Breast cancer

Keywords

Minneamrita | minnelide | Breast cancer | Pancreatic cancer